Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Plasma cell 2Lymphoid 2

Conditions

Multiple Myeloma 2Lymphoma 2Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Cancer Related Cognitive Difficulties 1

Interventions

Dexamethasone 122daratumumab 70Lenalidomide 69Bortezomib 57pomalidomide 46carfilzomib 42Cyclophosphamide 38Calcium Dobesilate 35Specimen Handling 31Biopsy 29Magnetic Resonance Spectroscopy 26isatuximab 21belantamab mafodotin 20fludarabine 19iberdomide 18talquetamab 17Melphalan 15dexamethasone acetate 14dexamethasone 21-phosphate 14auricularum 14fludarabine phosphate 12elotuzumab 12selinexor 10tocilizumab 9X-Rays 8Nivolumab 8trametinib 7Whole-Body Irradiation 7Sirolimus 7Mycophenolic Acid 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multiple Myeloma × Neuropsychological Tests × 90 days × Clear all
NCT07558057 2026-04-30

COGNITOX

University of Aarhus

Not yet recruiting
225 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Lymphoma, B-Cell, Marginal Zone

NCT04300998 2026-04-07

Study of CAR-T Therapy in Older Patients

Memorial Sloan Kettering Cancer Center

Recruiting
154 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡